Ana P M Canton
Overview
Explore the profile of Ana P M Canton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fink T, Canton A, Pereira M, Bain V, Matsuo O, Astley C, et al.
Clinics (Sao Paulo)
. 2023 Nov;
78:100299.
PMID: 37988857
No abstract available.
2.
Montenegro L, Seraphim C, Tinano F, Piovesan M, Canton A, McElreavey K, et al.
Eur J Endocrinol
. 2023 Sep;
189(3):422-428.
PMID: 37703313
Background: Several rare loss-of-function mutations of delta-like noncanonical notch ligand 1 (DLK1) have been described in non-syndromic children with familial central precocious puberty (CPP). Objective: We investigated genetic abnormalities of...
3.
Canton A, Tinano F, Guasti L, Montenegro L, Ryan F, Shears D, et al.
Lancet Diabetes Endocrinol
. 2023 Jun;
11(8):545-554.
PMID: 37385287
Background: Identification of genetic causes of central precocious puberty have revealed epigenetic mechanisms as regulators of human pubertal timing. MECP2, an X-linked gene, encodes a chromatin-associated protein with a role...
4.
Brito V, Canton A, Seraphim C, Abreu A, Macedo D, Mendonca B, et al.
Endocr Rev
. 2022 Aug;
44(2):193-221.
PMID: 35930274
The etiology of central precocious puberty (CPP) is multiple and heterogeneous, including congenital and acquired causes that can be associated with structural or functional brain alterations. All causes of CPP...
5.
Lokulo-Sodipe O, Giabicani E, Canton A, Ferrand N, Child J, Wakeling E, et al.
Clin Endocrinol (Oxf)
. 2022 Mar;
97(3):284-292.
PMID: 35261046
Objective: Silver-Russell syndrome (SRS) causes short stature. Growth hormone (GH) treatment aims to increase adult height. However, data are limited on the long-term outcomes of GH in patients with molecularly...
6.
Ramos C, Canton A, Seraphim C, Faria A, Tinano F, Mendonca B, et al.
J Pediatr Endocrinol Metab
. 2021 Jul;
34(11):1371-1377.
PMID: 34298591
Objectives: Longer-acting gonadotropin-releasing hormone analogs (GnRHa) have been widely used for central precocious puberty (CPP) treatment. However, the follow-up of patients after this treatment are still scarce. Our aim was...
7.
Montenegro L, Labarta J, Piovesan M, Canton A, Corripio R, Soriano-Guillen L, et al.
J Clin Endocrinol Metab
. 2020 Jul;
105(10).
PMID: 32676665
Background: Central precocious puberty (CPP) has been associated with loss-of-function mutations in 2 paternally expressed genes (MKRN3 and DLK1). Rare defects in the DLk1 were also associated with poor metabolic...
8.
Bessa D, Maschietto M, Aylwin C, Canton A, Brito V, Macedo D, et al.
Clin Epigenetics
. 2018 Nov;
10(1):146.
PMID: 30466473
Background: Recent studies demonstrated that changes in DNA methylation (DNAm) and inactivation of two imprinted genes (MKRN3 and DLK1) alter the onset of female puberty. We aimed to investigate the...
9.
Wakeling E, Brioude F, Lokulo-Sodipe O, OConnell S, Salem J, Bliek J, et al.
Nat Rev Endocrinol
. 2016 Sep;
13(2):105-124.
PMID: 27585961
This Consensus Statement summarizes recommendations for clinical diagnosis, investigation and management of patients with Silver-Russell syndrome (SRS), an imprinting disorder that causes prenatal and postnatal growth retardation. Considerable overlap exists...
10.
Canton A, Costa S, Rodrigues T, Bertola D, Malaquias A, Correa F, et al.
Eur J Endocrinol
. 2014 Jun;
171(2):253-62.
PMID: 24878679
Background: The etiology of prenatal-onset short stature with postnatal persistence is heterogeneous. Submicroscopic chromosomal imbalances, known as copy number variants (CNVs), may play a role in growth disorders. Objective: To...